Indoco Remedies share news, announcements and annual reports
NSE: INDOCOBSE: 532612Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹209.50.
30 Oct: open ₹208.65, high ₹210.00, low ₹205.10
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,923 Cr1,173rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 60.20
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹132 crore of one-off items, the largest of them in the quarter to Jun 2026.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.88
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.10%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 3.2%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹132 crore of one-off items, the largest of them in the quarter to Jun 2026.
- −10.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 1.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.96
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 64,72755.0% delivered
Indoco Remedies share news and announcements
729 announcements, routine notices left out, newest first. Page 14 of 15.
Mar 2012
29 Mar · Corporate action
Board of Directors of the Company at the meeting held on March 29, 2012 have taken (subject to approval of members by way of Postal Ballot) the following decisions: (1) Alteration to Capital Clause of MOA of the Company to increase authorized capital from existing Rs 18.00 crores to Rs 25.00 crores. (2) Sub-division of Equity Shares of Rs.10/- each to Rs.2/- each. (3) Issue of Bonus shares in the ratio of 1 bonus equity share for every 2 existing equity shares held in the Company. Dispatch of bonus shares would be completed on or before May 27, 2012.22 Mar · Board meeting
To consider, inter alia, the following business: (a) To consider a prosposal for sub division of shares of Rs.10/- each. (b) To consider a proposal for increasing the Authorized Share Capital and Consequent amendments to Memorandum of Association of the Company. (c) To consider a proposal for issue of Bonus Shares.
Feb 2012
6 Feb · Change in Company Secretary
Mr. Sunil Joshi has been appointed as Company Secretary & Compliance Officer of the Company w.e.f. February 08, 2012 in place of Mr. Jagdish B. Salian who would retire as Company Secretary & Compliance Officer from February 07, 2012.2 Feb · Updates
Company has entered into a strategic business alliance with DSM Pharmaceutical Products (DPP) NV, a constituent of the Royal DSM NV, Austria. Under the agreement reached, DPP will market and sell eight active pharma ingredients and APIs manufactured by Indoco in Austria and other international markets.
Jan 2012
31 Jan · Board meeting
Inter-alia, for taking on record the un-audited financial results for the third quarter ended December 31, 2011.
Dec 2011
21 Dec · Management
Board of Directors at their meeting held on December 17, 2011 accepted the resignation of Mr. D. N. Mungale, as Director of the Company, with effect from December 09, 2011.
Oct 2011
22 Oct · Updates
At the meeting of the Board of Directors held on October 20, 2011, the decision to purchase additional Plots by the Company at a total cost of Rs. 20.97 crores at following locations was rectified : (1) R-94, TTC Industrial Area, MIDC, Rabale, Navi Mumbai. (2) R-95, TTC Industrial Area, MIDC, Rabale, Navi Mumbai. (3) Plot A-27 at MIDC, Patalganga Industrial Estate, Village Khaire, Tal. Kalapur, Dist. Raigad. (4) B-19, MIDC waluj, Aurangabad-431136. The plots will be used for the purpose of enhancing the manufacturing capabilities and R&D activities.22 Oct · Board meeting
At the meeting of the Board of Directors held on October 20, 2011, the letter dated September 08, 2011 received from Dr. M. R. Narvekar tendering his resignation as the Director of the Company was considered and after due consideration it was decided to accept his resignation with effect from October 20, 2011.
Sep 2011
29 Sep · Board meeting
Inter-alia, for taking on record the un-audited financial results for the second quarter ended September 30, 2011.
Aug 2011
Jul 2011
28 Jul · Results
5 Jul · Board meeting
Inter alia, for taking on record the un-audited financial results for the first quarter ended June 30, 2011.
Jun 2011
23 Jun · Meeting
Annual General Meeting of the Company will be held on July 28, 2011.Further the Register of Members and Share Transfer Books of the Company will remain closed from July 21, 2011 to July 28, 2011 (both days inclusive) for the purpose of payment of dividend for the year ended March 31, 2011.
May 2011
28 May · Dividend
Board of Directors of the Company at its Meeting held on May 28, 2011 has decided to recommend a dividend of Rs.8/- per equity share of Rs.10/- each of the Company (80%) for the year ended March 31, 2011. The dividend when approved at the AGM will be paid on or after August 08, 2011 to those shareholders whose names appear on the register of members as on the record date.28 May · Results
11 May · Board meeting
To consider, inter-alia, the following businesses: (1) The audited financial results for the year ended March 31, 2011, and; (2) recommendation of final dividend, if any, for the financial year 2010-2011.
Apr 2011
27 Apr · Results
5 Apr · Board meeting
Inter-alia, to consider the Un-audited Financial Results for the last quarter ended March 31, 2011.
Jan 2011
4 Jan · Board meeting
Inter-alia, to consider the un-audited financial results for the third quarter ended December 31, 2010.
Oct 2010
22 Oct · Management
At the meeting of the Board of Directors held on October 20, 2010, the letter dated July 30, 2010 received from Mr. F. X. Coutinho tendering his resignation as the Wholetime Director-Marketing of the Company was considered and after due consideration it was decided to accept his resignation with effect from October 20, 2010. It was also decided that the vacancy caused by the resignation of Mr. Coutinho be not filled and the marketing function be overseen by Ms. Aditi Kare Panandikar.6 Oct · Board meeting
Inter-alia, to consider the un-audited financial results for the second quarter ended September 30, 2010.
Aug 2010
Jul 2010
14 Jul · Board meeting
Inter-alia, for taking on record the un-audited financial results for the first quarter ended June 30, 2010.
Jun 2010
21 Jun · Meeting
Register of Members and Share Transfer Books of the Company will remain closed from July 15, 2010 to July 22, 2010 (both days inclusive) for the purpose of payment of dividend @ Rs. 7/- per share (70%) for the year ended March 31, 2010 as recommended by the Board and if declared at the Annual General Meeting scheduled to be held on July 22, 2010.
May 2010
31 May · Dividend
Board of Directors of the Company at its Meeting held on May 31, 2010 has:- (1) Recommended payment of dividend of Rs.7.00 per equity share i.e. 70% for financial year 2009-10 subject to the approval of members in the ensuing Annual General Meeting.21 May · Board meeting
To consider, inter-alia, the following businesses: (1) To consider the audited financial results for the year ended March 31, 2010, and; (2) To consider recommendation of final dividend, if any, for the financial year 2009-2010.
Apr 2010
16 Apr · Board meeting
For considering, inter-alia, the unaudited financial results of the Company for the fourth quarter ended March 31, 2010.
Mar 2010
31 Mar · Business
Company has signed an agreement with Aspen Pharmacare, South Africa for supply of ophthalmic products. Under the agreement, Indoco will licence out the technology and supply the products. Aspen will market the products in emerging markets. It is expected that the arrangement would boost sale proceeds of the Company.
Feb 2010
1 Feb · Updates
Indoco Remedies Limited has entered into a business partnership with Watson Pharmaceuticals, Inc., USA. Under the agreement, Indoco will develop, manufacture and supply sterile products to Watson for the US market. The agreement is expected to bring considerable business to the Company and boost its turnover
Jan 2010
30 Jan · Rating
ICRA, the credit rating agency, has reaffirmed credit ratings for the Company's Commercial Paper as A1+ and LA+ for the long term borrowings. A1+ rating indicates highest credit quality rating and LA+ rating indicates adequate credit quality rating13 Jan · Board meeting
Meeting on 27 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
Oct 2009
15 Oct · Board meeting
Meeting on 30 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009”
Sep 2009
30 Sep · Meeting
Minutes of the Annual General Meeting of the Company held on September 18, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2009
26 Aug · Meeting
Register of Members and Share Transfer Books of the Company will remain closed from September 11, 2009 to September 18, 2009 (both days inclusive) for purposes of the payment of final dividend for the year ended March 31, 2009. The Annual General Meeting for the financial year 2008-09 is scheduled to be held on September 18, 2009.
Jul 2009
30 Jul · Dividend
At the meeting of the Board of Directors held on July 30, 2009, the Board has decided to declare a final dividend of Rs. 2.00 per equity share (20%). With the declaration of the final dividend, the dividend for the financial year 2008-09 works out to Rs. 5.25 per equity share (52.50%).16 Jul · Board meeting
To consider, inter-alia, the following businesses: (a) To consider and take on record the unaudited financial results of the company for the quarter ended June 30, 2009, (b) To consider the audited financial results for the year ended March 31, 2009 and (c) To consider recommendation of final dividend, if any, for the financial year 2008-2009.
Apr 2009
13 Apr · Board meeting
To consider inter-alia, the unaudited financial results of the Company for the fourth quarter ended March 31, 2009.
Feb 2009
6 Feb · Disclosure
With reference to the recently introduced new regulation 8A under SEBI (Substantial Acquisition of Shares and Takeover Regulations), 1997, we wish to state that the promoters and promoter group have not pledged any of their shares held in the Company and consequently are not required to make any disclosures to the Company. We therefore confirm that none of their shares held by the Promoter and Promoter Group in the Company have been pledged.
Jan 2009
22 Jan · Amendments to Memorandum of Association
Resolutions passed through postal ballot under section 192 (2A) for amendment of Clause 46 of object clause in the memorandum of association. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.13 Jan · Board meeting
Meeting on 30 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”7 Jan · Results
Result of postal ballot in respect of resolutions as set out in the notice dated October 31, 2008 pursuant section 192A of the Companies Act, 1956 was declared on January 07, 2009 on the basis of the report of the scrutinizer dated January 07, 2009. From the report of the scrutinizer it is observed that the resolutions have been approved by the shareholders with requisite majority. The details of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Dec 2008
2 Dec · Meeting
Pursuant to section 192A of the Companies Act, 1956 read with the Companies (Passing of the Resolutions by Postal Ballot) Rules, 2001, the approval of the shareholders for the following resolutions are required to be obtained by means of a postal ballot for (1) Ordinary Resolution u/s 293(1)(a) of the Companies Act, 1956 to transfer, sell and/or dispose of the Company's undertaking at 18A Mahal Estate, Andheri, Mumbai. (2) Special Resolution u/s 17 and 149 (2A) of the Companies Act, 1956 for alteration to the object clause of Memorandum of Association of the Company and commencement of new business. The Board of Directors at its meeting held on October 31, 2008 has appointed Shri Ajit Y. Sathe, Practising Company Secretary as the Scrutinizer to receive and Scrutinize the completed ballot papers from the members. The duly completed postal ballot form, reach the Scrutinizer on or before December 30, 2008 . The Scrutinizer will submit his report to the Chairman of the Company after completion of the scrutiny and the results of the postal ballot will be announced on January 7, 2009. A copy of the Postal Ballot notice shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2008
26 Nov · Dividend
Board of Directors of the Company at its meeting held on November 26, 2008, the Board has declare an interim dividend of Rs. 3.25 per share (32.5%) for the financial year 2008-09. It was also decided by the Board to keep December 12, 2008, as the record date for the purpose of payment of said dividend.18 Nov · Board meeting
For the purpose of considering a proposal for declaration of an interim dividend for the financial year 2008-2009.